Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers
Clinical trial NCT01190878 · COMPLETED
Trial details
- NCT number
- NCT01190878
- Sponsor
- Sun Pharmaceutical Industries Limited
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2011-01-01
- Enrollment
- 169
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.